.ppt
-
Upload
hondafanatics -
Category
Documents
-
view
221 -
download
1
Transcript of .ppt
USMLE Step 1 Review
James Paparello, M.D.
Department of Nephrology
Northwestern University
Email: [email protected]
Renal Physiology and Tubular function
Body Water50-60 % of body weight
Total Body Water
Intracellular Water Extracellular Water (2/3 total body water) (1/3 total body water)
Intravascular(1/4) Extravascular (3/4) (Plasma)
Body Water Calculation
Body Weight = 70 kg (154 lbs)
Total Body Water (TBW) = 60 % of Weight = 42 Kg• Intracellular Water = 2/3 of TBW = 28 Kg• Extracellular Water (ECV) = 1/3 of TBW = 14 Kg
– Extravascular water = ¾ of ECV = 10.5 Kg– Intravascular water = ¼ of ECV = 3.5 Kg = Plasma water
Blood Volume = Plasma Water/(1 – Hct) = 6.4 Kg (assign Hct of .45)
First Aid:
• TBW = ICF + ECF• 60 – 40 – 20 rule (% of Total body
weight)
Inulin
• ECF = Plasma volume + Interstitial volume¼ ¾
Albumin
Edema
Two requirements:• Alteration in capillary hemodynamics favoring movement of fluid out of
vascular space (into interstitium)
• Renal retention of Na+ and water
Starling’s Law:
LpS[(Pcap – Pif) – σ(πcap – πif)]
Lp = porosity, S = surface area, σ = reflection coefficient of proteins
Differences are between hydrostatic and oncotic pressures (capillary and interstitial)
Capillary Fluid Exchange
Filtration pressure = LpS[(Pcap – Pif) – σ(πcap – πif)]
Increased Pcap: Heart failure
Decreased πcap: Nephrotic syndrome, liver failure
Increased Capillary permeability (Kf = LpS): infections, toxins, burns
Increased πif : Lymphatic blockage
Remember:
• The glomerulus is a specialized capillary network:
• GFR = Kf [(Pgcap – Pbowman) – σ(πgcap – πbowman)]
Remember:
• The glomerulus is a specialized capillary network:
• GFR = Kf [(Pgcap – Pbowman) – σ(πgcap – πbowman)]
• GFR = Amount excreted = Urine concentration x V
Plasma conc. Plasma conc.
GFR calculation
GFR = Uinulin x V/Pinulin = Cinulin
We use creatinine instead of inulin (only a small amount of creatinine is secreted)
Normal GFR ~ 120 cc/min
Clearance Calculations
Px * Cx = Ux * V
Cx = (Ux * V)/Px
If Cx < GFR, then tubular reabsorption of x
If Cx > GFR, then tubular secretion of x
If Cx = GFR (e.g. inulin), there is not net absorption or secretion
Downloaded from: StudentConsult (on 28 November 2009 01:26 AM)
© 2005 Elsevier
You develop a drug that blocks tubular reuptake of urea. What happens to urea clearance ?
1 2 3
0% 0%0%
1. It increases
2. It decreases
3. No change, as the GFR does not change
Glucose Clearance
• At plasma glucose of > 200-300 mg/dl, tubular reabsorption is saturated, and glycosuria occurs.– Tm = maximal transport (for glucose, reabsorption) of a
solute.
– If glycosuria, blood sugar concentration > 200, so patient may have diabetes.
Downloaded from: StudentConsult (on 28 November 2009 01:26 AM)
© 2005 Elsevier
Plamsa Glucose: 95 mg/dL
Filtered glucose = 95
Reabsorbed Glucose = 95
Glucose in urine = 0
Plamsa Glucose: 375 mg/dL
Filtered glucose = 375
If max tubular absorption is 200 mg/dL:
Reabsorbed Glucose = 200
Glucose in urine = 175
Clearance of Free Water
• CH2O = V – Cosm
• V = urine flow rate
• Cosm = (Uosm * V)/Posm
– So if CH2O is positive, the kidney is excreting free water (dilute urine)
– If CH2O is negative, the kidney is retaining free H2O (excreting concentrated urine)
Renal Plasma Flow
Renal plasma flow = Plasma flow glomerulus + plasma flow tubules
PAH is actively secreted by the tubules, so PAH in the blood that does not go through the glomerulus (1 – FF = 0.8) is cleared by tubular excretion. Therefore, PAH clearance accounts for both blood through the glomerulus (FF) and the blood through the tubules.
Therefore: Effective renal plasma flow = (UPAH * V)/PPAH
Renal Blood Flow = Renal Plasma Flow/(1 – HCT)
Filtration Fraction
Fraction of the material that enters the kidney and is filtered (normally 0.20)
FF = GFR/RPF = 120/600 = 0.2
Netter, Atlas of Human Anatomy, 1989, Plate 322
Renal Hemodynamics
Glomerular Filtration Barrier
Three components:
1) Fenestrated Capillary Endothelium (size barrier)
2) Fused basement membrane with heparan sulfate (negative charge barrier)
3) Epithelial layer consisting of podocyte foot processes
Afferent/Efferent Hemodynamics
Glomerulus with capillary loops surrounded by Bowman’s space
Afferent Arteriole Efferent Arteriole
Blood Flow
Proximal Tubule (continuation of urinary space)
Afferent/Efferent Hemodynamics:Dilation of Afferent Artery
Glomerulus with capillary loops surrounded by Bowman’s space
Afferent Arteriole Efferent Arteriole
Blood Flow
Proximal Tubule (continuation of urinary space)
Renal Hemodynamics
Renal Hemodynamics
Dilation of Afferent Artery
• Caused by:– Prostaglandins
• Physiologic Changes Glomerular capillary pressure Nephron Plasma Flow, GFR
Filtration fraction:Afferent Artery Dilation
GFR So min. change in FF.
RPF
Afferent/Efferent Hemodynamics: Constriction of Afferent Artery
Glomerulus with capillary loops surrounded by Bowman’s space
Afferent Arteriole Efferent Arteriole
Blood Flow
Proximal Tubule (continuation of urinary space)
Renal Hemodynamics
Renal Hemodynamics
Constriction of Afferent Artery
• Caused by – NSAIDs (decrease prostaglandin production)
• Physiologic results: Glomerular capillary pressure Nephron plasma flow, GFR
N.B. Afferent arteriolar changes happen before the glomerulus, so no change in filtration fraction.
Filtration fraction:Afferent Arteriole Constriction
GFR So no change in FF
RPF
Afferent/Efferent Hemodynamics:Efferent Arteriole Dilation
Glomerulus with capillary loops surrounded by Bowman’s space
Afferent Arteriole Efferent Arteriole
Blood Flow
Proximal Tubule (continuation of urinary space)
Renal Hemodynamics
Renal Hemodynamics
Efferent Arteriole Dilation
• Caused by:– ACE-I, ARB
• Physiologic results: Glomerular capillary pressure Nephron Plasma flow, but GFR ( **N.B.
Decreases filtration fraction)
Filtration fraction:
GFR So filtration fraction decreases.
RPF
Afferent/Efferent Hemodynamics:Efferent Arteriole Constriction
Glomerulus with capillary loops surrounded by Bowman’s space
Afferent Arteriole Efferent Arteriole
Blood Flow
Proximal Tubule (continuation of urinary space)
Renal Hemodynamics
Renal Hemodynamics
Efferent Arteriole Constriction
• Caused by:– Angiotensin II
• Physiologic results: Glomerular capillary pressure Nephron Plasma flow, but GFR ( **N.B.
Increases filtration fraction)
Filtration fraction:
GFR so increased FF
RPF
N.B. efferent arteriole changes cause opposite effects on GFR and RPF
Which of the following would be expected to result in an increase in GFR soon after administration ?
1 2 3 4
0% 0%0%0%
1. ACE-Inhibitors
2. Angiotensin receptor blockers
3. Non-steroidal anti-inflammatory medications
4. Prostaglandins
Other Changes in Renal Function
GFR FF(GFR/RPF)
Increased Plasma Protein (πgcap)
Decreased Plasma Protein (πgcap)
Ureteral Blockage
Note: None of the above change RPF, hence FF goes in the direction of the GFR
Remember:
• The glomerulus is a specialized capillary network:
• GFR = Kf [(Pgcap – Pbowman) – σ(πgcap – πbowman)]
• GFR = Amount excreted = Urine concentration x V
Plasma conc. Plasma conc.
Tubular Function
Renal Sodium Handling
Downloaded from: StudentConsult (on 28 November 2009 03:14 AM)
© 2005 Elsevier
Downloaded from: StudentConsult (on 28 November 2009 03:14 AM)
© 2005 Elsevier
Proximal Tubule Cell(Figure from Up to Date, ed. B.D. Rose)
Renal Sodium Handling
Proximal Tubule Cell
Proximal Tubule Diuretic
• Acetazolamide inhibits carbonic anhydrase
• Carbonic Anhydrase promotes the absorption of sodium with bicarbonate
• Inhibiting carbonic anhydrase causes less sodium reabsorption and less bicarbonate reabsorption/H+ secretion
Proximal Tubule Cell
Acetazolamide
• Causes less Bicarbonate absorption (less H+ excretion)
• Less Sodium absorption (sodium absorbed by H+/Na+ antiport)
Acetazolamide
• Although works in the proximal tubule, it is a weak diuretic (the rest of the nephron can compensate for the sodium being lost)
• Can cause a non-gap acidosis– The A in DURHAM
• Used to treat metabolic alkalosis, particularly if volume overloaded
Downloaded from: StudentConsult (on 28 November 2009 03:14 AM)
© 2005 Elsevier
Downloaded from: StudentConsult (on 28 November 2009 03:14 AM)
© 2005 Elsevier
Thick Ascending Limb Cell(Figure from Up to Date, ed. B.D. Rose)
Renal Sodium Handling
Thick Ascending Limb Cell(Figure from Up to Date, ed. B.D. Rose)
Diuretics: Loop
• Agents: Furosemide (Lasix), Torsemide (Demadex), Bumetanide (Bumex)
• Inhibit the Na+-K+-2Cl- symporter in the thick ascending limb of the loop of Henle.
• Side effects: Fluid and electrolyte imbalances, volume depletion, ototoxicity, hyperuricemia, hyperglycemia, increased LDL and triglycerides
• Used for volume overload (rapid diuresis). Used for HTN particularly in chronic kidney disease. Can also be used with normal saline to treat hypercalcemia.
Downloaded from: StudentConsult (on 28 November 2009 03:14 AM)
© 2005 Elsevier
Downloaded from: StudentConsult (on 28 November 2009 03:14 AM)
© 2005 Elsevier
Distal Convoluted Tubule Cell(Figure from Up to Date, ed. B.D. Rose)
Renal Sodium Handling
Distal Convoluted Tubule Cell(Figure from Up to Date, ed. B.D. Rose)
Distal Convoluted Tubule Cell(Figure from Up to Date, ed. B.D. Rose)
Diuretics: Distal Convoluted Tubule
• Class often called Thiazides because hydrochlorothiazide is the most well known and recognized– Hydrochlorothiazide (HCTZ), Chlorthalidone, Metolazone
• Inhibit the Na – Cl symporter in the distal convoluted tubule.
• Side effects: Impotence, fluid and electrolyte imbalances, impaired glucose tolerance, and increased cholesterol
• Used to treat hypertension. Also can be used to reduce the risk of kidney stones in patients with hypercalciuria
Downloaded from: StudentConsult (on 28 November 2009 03:14 AM)
© 2005 Elsevier
Downloaded from: StudentConsult (on 28 November 2009 03:14 AM)
© 2005 Elsevier
Principal Cell (Collecting tubule)(Figure from Up to Date, ed. B.D. Rose)
Renal Sodium Handling
Principal Cell (Collecting tubule)(Figure from Up to Date, ed. B.D. Rose)
This cell also has luminal water channels mediated by a basal V2 receptor (ADH receptor)
Note, the more sodium delivered here, the more K+ excretion
Principal Cell : Effect of Aldosterone
(Figure from Up to Date, ed. B.D. Rose)
Principal Cell: Spironolactone(Figure from Up to Date, ed. B.D. Rose)
Principal Cell: Spironolactone(Figure from Up to Date, ed. B.D. Rose)
Principal Cell: Amiloride(Figure from Up to Date, ed. B.D. Rose)
Principal Cell: Amiloride(Figure from Up to Date, ed. B.D. Rose)
Diuretics: K+ Sparing
• Agents: Triamterene, Amiloride, Spironolactone, Eplerenone
• Mechanism:– Triamterene and Amiloride inhibit renal epithelial Na+ channels in
the late distal tubule and collecting duct. – Spironolactone and Eplerenone antagonize the mineralocorticoid
receptor on epithelial calls in the late distal tubule and cortical collecting duct.
• Side effects: – Amiloride and Triamterene: Hyperkalemia, nausea, vomiting– Spironolactone: Hyperkalemia, gynecomastia
• Adjunctive treatments with diuretics to avoid hypokalemia. Use caution if at risk for hyperkalemia.
Which diuretic causes the most sodium loss after one dose ?
1 2 3 4
0% 0%0%0%
1. Acetazolamide
2. Thiazide
3. Loop (e.g. furosemide)
4. Potassium sparing (e.g. amiloride)
Downloaded from: StudentConsult (on 28 November 2009 03:14 AM)
© 2005 Elsevier
Juxtaglomerular Appartus(Figure Taken from Up to Date, ed. By B.D. Rose)
Renin Angiotensin System (RAS)
Angiotensinogen
Renin
Angiotensin I
Angiotensin Converting Enzyme
Angiotensin II
Via Aldosterone
Sympathetic Activation Na/H2O Retention
Smooth Muscle Vasoconstriction Decreased Bradykinin
Adapted from Lippincott’s Illustrated Reviews: Pharmacology, 1992. P. 382.
RAS (Med Study)
1. Potent Vasoconstriction (A-II)
2. Aldosterone release
3. ADH release from posterior pituitary
4. Increased thirst (dipsogenic)
Renal Syndromes and Path
Light E.M.(From Up to Date)
Renal Path:Segmental and Global
No lesion Segemental lesions Global
Renal Path:Focal and Diffuse
Normal Focal Diffuse
< 50 % > 50 %
Crescent
Light E.M.(From Up to Date)
Renal Syndromes
Glomerular Tubular Uncertain Interstitial Diseases Asymptomatic U/A Findings
Nephrotic: Nephritic:Minimal Change Disease Immune complex mediatedFSGS Anti-GBM DiseaseMembranous Pauci-Immune(Diabetes, SLE)
Always look for underlying systemic disease (e.g. diabetes, paraproteinemia, vasculitis)Realize the disease can be acute (RPGN) or chronic
Nephritis
Nephritic Syndrome: Hematuria (glomerular), usually mild proteinuria, and hypertension
Classification of Glomerulonephritis
Immune Complex Pauci-Immune
IgA ANCA
SLE Wegner’s
PIGN Anti-GBM MPA
Churg-Straus
A 25 yo Japanese male comes to the office noticing his urine is darker, with a “rust” color. He has had a recent upper respiratory
infrection. He notes this has happened to him before. His urinalysis is notable for blood and protein in his urine.
1 2 3 4 5
0% 0% 0%0%0%
1. Lupus
2. PIGN
3. IgA nephropathy
4. Focal Segmental Glomerulosclerosis
5. Membranous GN
Renal Syndromes
Glomerular Tubular Uncertain Interstitial Diseases Asymptomatic U/A Findings
Nephrotic: Nephritic:Minimal Change Disease Immune complex mediatedFSGS Anti-GBM DiseaseMembranous Pauci-Immune(Diabetes, SLE)
Always look for underlying systemic disease (e.g. diabetes, paraproteinemia, vasculitis)Realize the disease can be acute (RPGN) or chronic
Nephrotic Syndrome
• > 3.5 gm protein/day
• Severe edema
• Hypoalbuminemia
• Hyperlipidemia
• Lipiduria
Nephrotic Syndrome
• Minimal Change Disease
• FSGS
• Membranous
• Amyloidosis
• Diabetes
0
20
40
60
80
100
120
0 5 16 35 55 100
MCDz
AMYLOID
DIABETES
MPGN
Other GN
FSGS
MEM
Approximate Frequency of Causes for Nephrotic Syndrome
Age
Acute Renal Failure/Oliguria
“ … a deterioration of renal function over a period of hours to days, resulting in the failure of the kidney to excrete nitrogenous waste products and to maintain fluid and electrolyte homeostasis.”
Rise in Serum Creatinine > 0.5 mg/dl over baseline
Etiology of Acute Renal Failure/Oliguria
Acute Renal Failure
Prerenal Intrinsic Postrenal
~ 70 % ~ 25 % ~ 5 %
Intrinsic Renal Failure
Intrinsic Causes
Tubular Interstitial Acute Necrosis Nephritis GN (10 %) (5 %)
Ischemia Toxins (50 %) (35 %)
NEJM Vol. 334, # 22 p. 1449 Fig. 1
Urinary Indices
Condition Prerenal ATN AGN Obs
U Osm > 500 <350 300-500+ 300-500*
U Na < 20 > 40 < 40 > 40
FE Na < 1 > 1 < 1 > 1
Cast formationCornell Website
Acid/Base
1. Determine pH status (alkalemia or acidemia)-Blood pH < 7.36 is acidemia, blood pH > 7.44 is alkalemia
2. Determine if primary process is respiratory or metabolic (or both)-Alkalosis: Respiratory if pCO2 is < 40, metabolic if HCO3 is > 25-Acidosis: Respiratory if pCO2 > 40, metabolic if HCO3 is < 25
3. Calculate Anion Gap [Na – (Cl +HCO3)]4. Check degree of compensation
Metabolic Acidosis: Decrease in pCO2 = 1.3 x decrease in bicarbonateMetabolic Alkalosis: Increase in pCO2 = 0.6 x increase in bicarbonateRespiratory Acidosis, Acute: Increase in 10 mmHG pCO2, increase HCO3 by 1Respiratory Acidosis, Chronic: Increase in 10 mmHG pCO2, increase HCO3 by 4Respiratory Alkalosis, Acute: Decrease in PCO2 of 10, decrease in HCO3 by 2Respiratory Alkalosis, chronic: Decrease in pCO2 of 10, decrease in HCO3 by 4
Acid/Base
5. Determine whether there is a 1:1 relationship between anions in the blood (delta – delta)
Increased Anion Gap metabolic acidosis: every 1 point increase in anion gap should be accompanied by a 1 mEq/L decrease in bicarbonate
Normal anion gap metabolic acidosis: every 1 mEq/L increase in chloride should be accompanied by a 1 mEq/L decrease in bicarbonate
Metabolic Acidosis
• Gap:– Methanol
– Uremia
– DKA
– Paraldehyde
– Infection/Ischemia
– Lactic
– Ethanol/Ethylene Glycol
– Salicylate
• Non-Gap– Diarrhea
– Ureteral Diversions
– RTA
– Hypocapnia
– Acetazolamide, Ampho B
– Mineralocorticoid deficiency
Metabolic Acidosis
• Primary disturbance is low serum bicarb., and pH is low
• PCO2 will decrease (Compensatory resp. alkalosis)
• DKA, Diarrhea, lactic acidosis
Metabolic Alkalosis
• Saline Responsive (U Cl < 10)– GI loss
• Upper – Vomiting, NG suction
• Lower – Diarrhea (with Cl-), adenoma
– Post hypercapnia
– Diuretics
• Saline resistant (U CL > 20)– Alkali Ingestion
– Adrenal Excess• Hyperaldosteronism
• Cushing’s Disease
• Meds. (steroids)
– Bartter’s syndrome
– Gitelman’s syndrome
– Liddle’s syndrome
– Licorice
– “Refeeding” alkalosis
Metabolic Alkalosis
• Primary disturbance is high serum bicarbonate, and pH is high
• PCO2 increases (compensatory resp. acidosis)
• Vomiting
Respiratory Acidosis
• Pulmonary Disease
• Laryngospasm
• Pleural Disease
• Impaired Respiratory Mechanics(sedation, weakness)
Respiratory Acidosis
• Primary disturbance is high pCO2, and pH is low
• Serum bicarb. Increases – compensatory metabolic alkalosis
• COPD, airway obstruction
Respiratory Alkalosis
• Sepsis
• Severe liver disease
• CNS injury (CVA, infection)
• Medications (CNS stimulant, ASA)
• Hyperthyroidism
• Pulmonary causes (hypoxia, ventilators)
Respiratory Alkalosis
• Primary disturbance is decrease in PCO2, and pH is high
• Serum HCO3 decreases, compensatory metabolic acidosis
• Hyperventilation, high altitude
What is the following acid base abnormality ? Na: 141, K: 3.3, Cl: 86, HCO3: 25.
pH: 7.40 pCO2: 41
1 2 3 4
0% 0%0%0%
1. No disturbance
2. Metabolic acidosis
3. Metabolic acidosis and Respiratory alkalosis
4. Metabolic acidosis and metabolic alkalosis
Acid/Base
1. Determine pH status (alkalemia or acidemia)-Blood pH < 7.36 is acidemia, blood pH > 7.44 is alkalemia
2. Determine if primary process is respiratory or metabolic (or both)-Alkalosis: Respiratory if pCO2 is < 40, metabolic if HCO3 is > 25-Acidosis: Respiratory if pCO2 > 40, metabolic if HCO3 is < 25
3. Calculate Anion Gap [Na – (Cl +HCO3)]4. Check degree of compensation
Metabolic Acidosis: Decrease in pCO2 = 1.3 x decrease in bicarbonateMetabolic Alkalosis: Increase in pCO2 = 0.6 x increase in bicarbonateRespiratory Acidosis, Acute: Increase in 10 mmHG pCO2, increase HCO3 by 1Respiratory Acidosis, Chronic: Increase in 10 mmHG pCO2, increase HCO3 by 4Respiratory Alkalosis, Acute: Decrease in PCO2 of 10, decrease in HCO3 by 2Respiratory Alkalosis, chronic: Decrease in pCO2 of 10, decrease in HCO3 by 4
Acid/Base
5. Determine whether there is a 1:1 relationship between anions in the blood (delta – delta)
Increased Anion Gap metabolic acidosis: every 1 point increase in anion gap should be accompanied by a 1 mEq/L decrease in bicarbonate
Normal anion gap metabolic acidosis: every 1 mEq/L increase in chloride should be accompanied by a 1 mEq/L decrease in bicarbonate
• Good luck
• The fact that you’re here (at NW) = high likelihood of success
• P = M.D.
“Success is peace of mind attained only through self-satisfaction in knowing you’ve made the effort to the best of which you’re capable.
People ask me: Have you lived up to your pyramid ?
My answer is always the same: No, but I have tried.”
- John Wooden